Nexalin Technology Stock Performance
| NXL Stock | USD 3.90 0.08 2.09% |
Nexalin Technology holds a performance score of 18 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 1.45, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nexalin Technology will likely underperform. Use Nexalin Technology semi variance, as well as the relationship between the daily balance of power and price action indicator , to analyze future returns on Nexalin Technology.
Risk-Adjusted Performance
18 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Nexalin Technology are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite quite abnormal basic indicators, Nexalin Technology disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 5.4 | Five Day Return 10.78 | Year To Date Return 931.89 | Ten Year Return 82.67 | All Time Return 82.67 |
1 | Up 186 percent in 2024, this ASX tech stock still trades at a significant discount to global peers | 09/18/2024 |
2 | Acquisition by Marilyn Elson of 700000 shares of Nexalin Technology subject to Rule 16b-3 | 09/23/2024 |
3 | Acquisition by Hu Ben of 175000 shares of Nexalin Technology subject to Rule 16b-3 | 09/30/2024 |
4 | Acquisition by Morad Rick of 2500 shares of Nexalin Technology at 4.15 subject to Rule 16b-3 | 10/07/2024 |
5 | EXCLUSIVE Nano-Cap Nexalins Drug-Free Alternative For Alzheimers Shows Improved Memory, Cognitive Function In Small Study | 10/17/2024 |
6 | Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 10/25/2024 |
7 | EXCLUSIVE Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimers Patients | 10/28/2024 |
8 | Nexalin Technology, Inc. Short Interest Update | 10/30/2024 |
9 | Nuix Limiteds Retail Investors See Growth Amid Stock Rally | 11/05/2024 |
10 | Xero and 2 other ASX tech shares cracking all-time highs on Thursday | 11/07/2024 |
11 | Why Insignia, Light Wonder, Mineral Resources, and Nuix shares are sinking today | 11/13/2024 |
12 | Top broker says ASX 300 tech stock has 18 percent upside after sell-off | 11/14/2024 |
| Begin Period Cash Flow | 162.7 K |
Nexalin |
Nexalin Technology Relative Risk vs. Return Landscape
If you would invest 93.00 in Nexalin Technology on August 28, 2024 and sell it today you would earn a total of 297.00 from holding Nexalin Technology or generate 319.35% return on investment over 90 days. Nexalin Technology is generating 2.9855% of daily returns assuming volatility of 12.511% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Nexalin, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Nexalin Technology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nexalin Technology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nexalin Technology, and traders can use it to determine the average amount a Nexalin Technology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2386
| Best Portfolio | Best Equity | |||
| Good Returns | NXL | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.51 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.99 actual daily | 59 59% of assets have lower returns |
Risk-Adjusted Return
| 0.24 actual daily | 18 82% of assets perform better |
Based on monthly moving average Nexalin Technology is performing at about 18% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nexalin Technology by adding it to a well-diversified portfolio.
Nexalin Technology Fundamentals Growth
Nexalin Stock prices reflect investors' perceptions of the future prospects and financial health of Nexalin Technology, and Nexalin Technology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nexalin Stock performance.
| Return On Equity | -2.02 | ||||
| Return On Asset | -1.19 | ||||
| Operating Margin | (48.32) % | ||||
| Current Valuation | 47.22 M | ||||
| Shares Outstanding | 12.86 M | ||||
| Price To Book | 10.12 X | ||||
| Price To Sales | 334.05 X | ||||
| Revenue | 110.75 K | ||||
| Gross Profit | 958.14 K | ||||
| EBITDA | (5.69 M) | ||||
| Net Income | (4.65 M) | ||||
| Cash And Equivalents | 291.33 K | ||||
| Cash Per Share | 0.06 X | ||||
| Total Debt | 4.46 K | ||||
| Current Ratio | 0.20 X | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | (3.84 M) | ||||
| Earnings Per Share | (0.65) X | ||||
| Market Capitalization | 50.16 M | ||||
| Total Asset | 3.63 M | ||||
| Retained Earnings | (77.04 M) | ||||
| Working Capital | 3 M | ||||
About Nexalin Technology Performance
By examining Nexalin Technology's fundamental ratios, stakeholders can obtain critical insights into Nexalin Technology's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Nexalin Technology is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 2.2 K | 2.3 K | |
| Return On Tangible Assets | (1.32) | (1.38) | |
| Return On Capital Employed | (1.78) | (1.69) | |
| Return On Assets | (1.28) | (1.34) | |
| Return On Equity | (1.45) | (1.38) |
Things to note about Nexalin Technology performance evaluation
Checking the ongoing alerts about Nexalin Technology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nexalin Technology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nexalin Technology is way too risky over 90 days horizon | |
| Nexalin Technology appears to be risky and price may revert if volatility continues | |
| Nexalin Technology has 4.46 K in debt. Nexalin Technology has a current ratio of 0.2, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Nexalin to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 110.75 K. Reported Net Loss for the year was (4.65 M) with profit before taxes, overhead, and interest of 958.14 K. | |
| Nexalin Technology has about 291.33 K in cash with (3.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
| Nexalin Technology has a frail financial position based on the latest SEC disclosures | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from fool.com.au: Top broker says ASX 300 tech stock has 18 percent upside after sell-off |
- Analyzing Nexalin Technology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nexalin Technology's stock is overvalued or undervalued compared to its peers.
- Examining Nexalin Technology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nexalin Technology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nexalin Technology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nexalin Technology's stock. These opinions can provide insight into Nexalin Technology's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.65) | Revenue Per Share 0.02 | Quarterly Revenue Growth (0.24) | Return On Assets (1.19) | Return On Equity (2.02) |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.